Larson Financial Group’s AgomAb Therapeutics NV AGMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-698
Closed -$9.06K – 4059
2026
Q2
$9.06K Buy
+698
New +$7.86K ﹤0.01% 2466

Other funds holding AGMB

Larson Financial Group's AGMB Position: Q3 2026 in Review

Larson Financial Group sold out of AgomAb Therapeutics NV (AGMB) in Q3 2026, closing a stake of 698 shares — an estimated $9.06K sold.

Larson Financial Group first reported a position in AGMB in Q2 2026 and held it in 1 quarter. The position peaked at $9.06K in Q2 2026. 25 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.

  • Larson Financial Group reported no remaining AgomAb Therapeutics NV position as of Q3 2026 after selling out during the quarter.
  • Larson Financial Group sold 698 AgomAb Therapeutics NV shares in Q3 2026, an estimated $9.06K.
  • Larson Financial Group first reported a position in AgomAb Therapeutics NV in Q2 2026 and held it in 1 quarter.
  • Larson Financial Group's AgomAb Therapeutics NV position peaked at $9.06K in Q2 2026.
  • 25 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.